The European Lung Foundation (ELF)Founded by ERS in 2000, ELF brings together patients and the public with respiratory professionals to positively influence lung health.Visit the ELF site
Home ERS Respiratory Channel ERS guideline on withdrawal of inhaled corticosteroids in COPD
Chairs: Marc Miravitlles (Barcelona, Spain); Speaker: James Chalmers (Dundee, United Kingdom)
There is frequent inappropriate use of inhaled corticosteroids (ICS) in COPD. ICS are useful in prevention of exacerbations, but an increasing number of patients with mild COPD and infrequent exacerbations are being treated with ICS. The long-term use of ICS is associated with increases risk of side effects, such as pneumonia; therefore, strategies for safe ICS withdrawal are important in clinical practice.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Undefined cookies are those that are being analyzed and have not been classified into a category as yet.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.